title: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART?
abstract: Several studies have investigated a variety of nutritional supplementation interventions in adults with HIV. In this narrative review, we summarize the evidence from 31 clinical trials that explore clinical benefits of macronutrient and micronutrient supplementation in this population while attempting to answer the question of whether good nutrition can delay the time to highly active antiretroviral therapy (HAART) initiation and response. We focused on trials published in English between 1990 and 2010 that reported on CD4 count, viral load, and disease progression or survival. Among 9 macronutrient and 22 micronutrient trials, we found that evidence for improved CD4 count and HIV viral load with nutritional supplementation was limited; only 11.1% and 36.8% of macronutrient and micronutrient supplementation trials, respectively, reported improved CD4 count; and 33.3% and 12.5% of macronutrient and micronutrient trials, respectively, reported decreased viral load. Given their utility as surrogate markers of HIV disease progression, this suggests limited evidence for nutritional interventions having an impact on delaying HAART initiation or on improving HAART response. However, there are challenges in evaluating the effects of nutritional supplementation on clinical disease in that comparisons are difficult due to heterogeneity in study design, patient population, nutrient doses and combinations, baseline levels of deficiency, and study endpoints, including lack of clarity in defining and reporting HAART status. Future studies need to adopt a more rigorous standard design with adequate power and follow-up and require a consensus on composition and dose of nutrient interventions to be tested to more specifically answer the question on the impact of nutritional interventions on HIV disease progression and HAART response.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Aditya
authors.initials: A
authors.lastname: Chandrasekhar
authors.forename: Amita
authors.initials: A
authors.lastname: Gupta
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D004032:Diet; D019587:Dietary Supplements; D018450:Disease Progression; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006801:Humans; D018977:Micronutrients / Q000627:therapeutic use*; D044623:Nutrition Therapy; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D018977:Micronutrients
references.citation: Am J Clin Nutr. 2007 Feb;85(2):333-45
references.pmid: 17284727
references.citation: Platelets. 2001 Dec;12(8):456-61
references.pmid: 11798394
references.citation: PLoS Med. 2007 May;4(5):e115
references.pmid: 17472433
references.citation: Eur J Clin Nutr. 2001 Feb;55(2):107-14
references.pmid: 11305623
references.citation: Clin Infect Dis. 2007 Aug 15;45(4):470-4
references.pmid: 17638196
references.citation: JPEN J Parenter Enteral Nutr. 2000 May-Jun;24(3):133-9
references.pmid: 10850936
references.citation: J Am Diet Assoc. 1998 Apr;98(4):434-8
references.pmid: 9550167
references.citation: AIDS. 2003 Nov 21;17(17):2461-9
references.pmid: 14600517
references.citation: Cochrane Database Syst Rev. 2010 Dec 08;(12):CD003650
references.pmid: 21154354
references.citation: N Engl J Med. 2011 Jan 20;364(3):248-54
references.pmid: 21247315
references.citation: Am J Clin Nutr. 2008 Jun;87(6):1802-8
references.pmid: 18541571
references.citation: Am J Clin Nutr. 2008 Oct;88(4):1010-7
references.pmid: 18842788
references.citation: J Acquir Immune Defic Syndr (1988). 1993 Mar;6(3):272-6
references.pmid: 8450402
references.citation: AIDS. 1998 Sep 10;12(13):1653-9
references.pmid: 9764785
references.citation: Vitam Horm. 2007;75:355-83
references.pmid: 17368322
references.citation: Eur J Clin Invest. 2000 Jan;30(1):87-94
references.pmid: 10620007
references.citation: J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):190-5
references.pmid: 18769349
references.citation: Clin Chem Lab Med. 2005;43(4):376-82
references.pmid: 15899652
references.citation: Eur J Clin Nutr. 2006 Nov;60(11):1266-76
references.pmid: 16721396
references.citation: Br J Nutr. 1999 Mar;81(3):181-9
references.pmid: 10434844
references.citation: Am J Clin Nutr. 2008 Nov;88(5):1313-21
references.pmid: 18996868
references.citation: Ann Nutr Metab. 2007;51(4):301-23
references.pmid: 17726308
references.citation: Br J Nutr. 2003 Apr;89(4):475-82
references.pmid: 12654165
references.citation: Eur J Clin Nutr. 2006 Jul;60(7):862-9
references.pmid: 16452912
references.citation: Curr Opin HIV AIDS. 2011 Jul;6(4):266-71
references.pmid: 21546831
references.citation: Free Radic Biol Med. 2002 Mar 1;32(5):414-20
references.pmid: 11864781
references.citation: AIDS. 1996 Aug;10(9):967-73
references.pmid: 8853729
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):44-51
references.pmid: 9928729
references.citation: JPEN J Parenter Enteral Nutr. 2002 Jan-Feb;26(1):6-14
references.pmid: 11833753
references.citation: N Engl J Med. 2004 Jul 1;351(1):23-32
references.pmid: 15229304
references.citation: Nutrition. 2004 Jun;20(6):515-20
references.pmid: 15165613
references.citation: Clin Infect Dis. 2010 Jul 1;51(1):51-7
references.pmid: 20509768
references.citation: Clin Infect Dis. 2009 Sep 1;49(5):787-98
references.pmid: 19624276
references.citation: J Infect Dis. 2008 Jun 1;197(11):1499-505
references.pmid: 18471061
references.citation: Curr HIV/AIDS Rep. 2011 Sep;8(3):133-41
references.pmid: 21647555
references.citation: AIDS. 2007 Jan 30;21(3):335-41
references.pmid: 17255740
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15;15(5):370-4
references.pmid: 9342257
references.citation: Int J Tuberc Lung Dis. 2003 Aug;7(8):804-7
references.pmid: 12921158
references.citation: J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):523-8
references.pmid: 16868496
references.citation: Clin Infect Dis. 2010 Jun 15;50(12):1653-60
references.pmid: 20455705
references.citation: Lancet. 2006 Mar 11;367(9513):817-24
references.pmid: 16530575
references.citation: Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003650
references.pmid: 16235333
references.citation: Am J Clin Nutr. 2011 Dec;94(6):1683S-1689S
references.pmid: 22089440
references.citation: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004536
references.pmid: 17636766
references.citation: J Infect Dis. 1998 Mar;177(3):611-6
references.pmid: 9498439
references.citation: J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1657-63
references.pmid: 15577425
references.citation: BMC Public Health. 2010 Jun 07;10:316
references.pmid: 20529283
references.citation: Int J Tuberc Lung Dis. 2004 Mar;8(3):286-98
references.pmid: 15139466
references.citation: AIDS. 1999 Mar 11;13(4):495-500
references.pmid: 10197378
references.citation: Clin Chem Lab Med. 2002 May;40(5):456-9
references.pmid: 12113287
references.citation: BMJ. 2009 May 22;338:b1867
references.pmid: 19465470
references.citation: Arch Intern Med. 2007 Jan 22;167(2):148-54
references.pmid: 17242315